First Time Loading...
B

Bioventus Inc
NASDAQ:BVS

Watchlist Manager
Bioventus Inc
NASDAQ:BVS
Watchlist
Price: 3.96 USD -0.75% Market Closed
Updated: May 3, 2024
Section:
 

Wall Street
Price Targets

BVS Price Targets Summary
Bioventus Inc

Wall Street analysts forecast BVS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BVS is 8.16 USD with a low forecast of 7.07 USD and a high forecast of 9.45 USD.

BVS Lowest Forecast
Wall Street Target
7.07 USD
79% Upside
BVS Average Forecast
Wall Street Target
8.16 USD
106% Upside
BVS Highest Forecast
Wall Street Target
9.45 USD
139% Upside
Lowest
Price Target
7.07 USD
79% Upside
Average
Price Target
8.16 USD
106% Upside
Highest
Price Target
9.45 USD
139% Upside

BVS Last Price Targets
Bioventus Inc

The latest public price target was made on Mar 13, 2024 by Alex Nowak from Craig-Hallum , who expects BVS stock to rise by 127% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Alex Nowak
Craig-Hallum
9 USD
Upside 127%
1 month ago
Mar 13, 2024
Bioventus Inc (BVS) PT Raised to $9 at Craig-Hallum
StreetInsider
Alex Nowak
Craig-Hallum
Price Target 9 USD
Upside/Downside 127%
View Source
Bioventus Inc Competitors:
Price Targets
J
OMED
Jayamas Medica Industri TBK PT
13% Upside
HAE
Haemonetics Corp
15% Upside
UFPT
UFP Technologies Inc
3% Downside
688016
Shanghai MicroPort Endovascular MedTech Group Co Ltd
30% Upside
J
OMED
Jayamas Medica Industri TBK PT
13% Upside
HAE
Haemonetics Corp
15% Upside
UFPT
UFP Technologies Inc
3% Downside
688016
Shanghai MicroPort Endovascular MedTech Group Co Ltd
30% Upside
M
688029
Micro-Tech Nanjing Co Ltd
41% Upside
MMSI
Merit Medical Systems Inc
24% Upside
ANN
Ansell Ltd
8% Upside
G
GENT
Gentian Diagnostics ASA
43% Upside

Revenue
Forecast

Revenue Estimate
Bioventus Inc

For the last 8 years the compound annual growth rate for Bioventus Inc's revenue is 10%. The projected CAGR for the next 4 years is 4%.

10%
Past Growth
4%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Bioventus Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Bioventus Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
BVS intrinsic value, competitors valuation, and company profile.
DCF Valuation
BVS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BVS stock valuation using valuation multiples.
Wall Street Estimates
BVS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BVS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BVS's stock price target?
Price Target
8.16 USD

According to Wall Street analysts, the average 1-year price target for BVS is 8.16 USD with a low forecast of 7.07 USD and a high forecast of 9.45 USD.

What is Bioventus Inc's Revenue forecast?
Projected CAGR
4%

For the last 8 years the compound annual growth rate for Bioventus Inc's revenue is 10%. The projected CAGR for the next 4 years is 4%.

ALPHA SPREAD
Join more than 133,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.